Sotradecol Injection, Solution
Product Images NDC 67457-162

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sotradecol (NDC 67457-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sodium Tetradecyl Sulfate Structural Formula (299c3a3f Da6e 439d 872f 15f761c152d8 01)

FDA Label Image

Sotradecol Injection 1% Carton Label (Image 01)

Sotradecol Injection 1% Carton Label (Image 01)
This is a description of a pharmaceutical product containing sodium tetradecyl sufate used for injection. The solution is presented in a pack of mL containing benzyl alcohol and sodium phosphate. Sodium hydroxide is added where necessary to adjust the pH. The product is for intravenous use only and should not be used if precipitated. The name of the product is not available as it's not clearly stated in the text.*
FDA Label Image

Sotradecol Injection 3% Carton Label (Image 02)

Sotradecol Injection 3% Carton Label (Image 02)
This is prescribing information for a Sodium Tetradecyl Sulfate injection. Each vial has 30mg of Sodium Teradecyl Sulfate, 0.02 ml of Benzyl Alcohol and 9.0 mg of dibasic sodium phosphate in water for injection. The pH of the solution is 7.0 and additional sodium phosphate and/or sodium hydroxide may be added to adjust the pH. It is warned not to use if precipitated. The usual dosage is not available. The product is for intravenous use only and comes in 5 x 2mL multiple-dose vials.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.